Effects of inhibitors on drug metabolism.
D002248:Carbon Monoxide / Q000494:pharmacology; D003486:Cyanides / Q000494:pharmacology; D003580:Cytochromes / Q000378:metabolism; D004336:Drug Antagonism; D004579:Electron Transport; D006900:Hydroxylation; D008748:Methylcholanthrene / Q000494:pharmacology; D008797:Metyrapone / Q000494:pharmacology; D008861:Microsomes / Q000378:metabolism; D009243:NAD / Q000378:metabolism; D009249:NADP / Q000378:metabolism; D010882:Piperonyl Butoxide / Q000494:pharmacology; D011335:Proadifen / Q000494:pharmacology; D013438:Sulfhydryl Compounds / Q000494:pharmacology
D003486:Cyanides; D003580:Cytochromes; D013438:Sulfhydryl Compounds; D009243:NAD; D009249:NADP; D008748:Methylcholanthrene; D002248:Carbon Monoxide; D011335:Proadifen; D010882:Piperonyl Butoxide; D008797:Metyrapone